Latest article
Xeris Prescription drugs Receives European Fee Approval of Ogluo™ (glucagon) Injection for the Therapy...
CHICAGO & DUBLIN - (BUSINESS WIRE) - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), ein Spezialpharmaunternehmen, das seine...
Attempt these Coronary heart Wholesome Recipes from the PA Beef Council | WTAJ
BEDFORD, Pa. (WTAJ) — February is American Heart Month and it's a great time to focus on how to incorporate more heart-healthy foods...
Poxel Presents New Outcomes of Imeglimin Part 2 and three Scientific Research in Japan...
Lyon, France - (BUSINESS WIRE) - POXEL SA (Euronext - POXEL - FR0012432516), a biopharmaceutical company...